RCM
SCLN

Rotella Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Rotella Capital Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,360
Closed -$91K – 653
2014
Q4 		$91K Sell
10,360
-9,700
-48% -$78.5K 0.08% 256
2014
Q3 		$138K Sell
20,060
-316
-2% -$1.89K 0.14% 140
2014
Q2 		$107K Buy
+20,376
New +$99.1K 0.09% 208
2014
Q1 		– Sell
-11,272
Closed -$57K – 281
2013
Q4 		$57K Buy
+11,272
New +$54.2K 0.11% 68
2013
Q3 		– Sell
-12,255
Closed -$61K – 179
2013
Q2 		$61K Buy
+12,255
New +$58.3K 0.19% 66

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Rotella Capital Management's SCLN Position: Q1 2015 in Review

Rotella Capital Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2015, closing a stake of 10,360 shares — an estimated $91K sold.

Rotella Capital Management first reported a position in SCLN in Q2 2013 and held it in 5 quarters. The position peaked at $138K in Q3 2014. 130 funds tracked by Wall St. Rank hold SCLN as of Q1 2015.

  • Rotella Capital Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Rotella Capital Management sold 10,360 Sciclone Pharmaceuticals Inc shares in Q1 2015, an estimated $91K.
  • Rotella Capital Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Rotella Capital Management's Sciclone Pharmaceuticals Inc position peaked at $138K in Q3 2014.
  • 130 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2015.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.